생물안전성 시험 서비스 시장에서 북미의 점유율은 어떻게 되나요?

2025년에는 북미가 33.3%의 최대 점유율을 기록할 것으로 예상됩니다.

생물안전성 시험 서비스 시장의 성장을 지원하는 요인은 무엇인가요?

생물제제 및 바이오시밀러의 채택 확대, 세포·유전자 치료에 대한 관심 증가, 그리고 제품 안전성에 관한 엄격한 규제 요건이 시장 성장을 지원하고 있습니다.

생물안전성 시험 서비스 수요의 변화는 어떻게 나타나고 있나요?

많은 제약사 및 바이오테크 기업이 생물학적 안전성 시험 수요를 전문 서비스 제공업체에 위탁하는 추세가 강화되고 있습니다.

계약연구기관(CRO)과 계약개발·제조기관(CDMO)의 역할은 무엇인가요?

CRO 및 CDMO는 비용 대비 효과가 높고, 규제를 준수하는 시험 솔루션을 제공하여 의약품 개발에 중요한 역할을 수행하고 있습니다.

시장보고서

상품코드

2112243

생물 안전 시험 서비스 시장 규모, 점유율 및 동향 분석 보고서 : 서비스별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Biological Safety Testing Services Market Size, Share & Trends Analysis Report By Services, By Application, By End-use, By Region, And Segment Forecasts, 2026 - 2033

발행일: 2026년 07월 | 리서치사: 구분자

Grand View Research | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

가격

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 5,950

￦ 8,166,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 6,950

￦ 9,539,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

US $ 8,950

￦ 12,284,000

※ 부가세 별도

한글목차

영문목차

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

생물안전성 시험 서비스 시장 요약

세계의 생물 안전성 시험 서비스 시장 규모는 2025년에 42억 달러로 평가되며, 2026년 47억 달러에서 2033년까지 110억 달러로 확대하며, 2026-2033년의 CAGR은 12.8%에 달할 것으로 예측됩니다.

북미가 시장을 주도하며, 2025년에는 33.3%라는 최대 점유율을 기록했습니다. 생물제제 및 바이오시밀러의 채택 확대, 세포·유전자 치료에 대한 관심 증가, 그리고 제품 안전성에 관한 엄격한 규제 요건이 생물제제 안전성 시험 서비스 업계의 성장을 지원하고 있습니다.

또한 바이오의약품 파이프라인의 확대와 수탁 시험 서비스의 확대가 맞물려 시장을 더욱 견인하고 있습니다. 자동화, 차세대 염기서열 분석(NGS), 중합효소 연쇄 반응(PCR) 기반 검사 등의 기술적 진보로 인해 효율성과 정확도가 향상되어 안전성 시험의 신뢰성이 높아지고 있습니다. 또한 바이오의약품 업계는 지난 수년간 놀라운 성장을 이루었습니다. Creative Biogene가 발표한 데이터에 따르면 현재 약 3,700개의 세포·유전자 치료 제품이 개발 파이프라인에 있으며, 전 세계에서 100개 이상의 치료법이 승인되었습니다. 세포·유전자 치료 제품의 파이프라인 확대와 규제 당국의 승인 건수 증가가 시장 성장을 크게 견인하고 있습니다. 이러한 첨단 치료법에서는 미생물이나 바이러스의 오염이 없음을 보장하기 위해 엄격한 안전성 평가가 요구됩니다. 따라서 세포·유전자 치료 제품 파이프라인이 계속 증가함에 따라 향후 1년 동안 이러한 서비스에 대한 수요가 높아질 것으로 예상됩니다.

또한 많은 제약사 및 바이오테크 기업은 사내 시험에 막대한 비용과 첨단 전문 지식이 필요하므로 생물학적 안전성 시험 수요를 전문 서비스 제공업체에 위탁하는 추세가 강화되고 있습니다. 계약연구기관(CRO) 및 계약개발·제조기관(CDMO)은 비용 대비 효과가 높고, 규제를 준수하는 시험 솔루션을 제공하는 데 있으며, 매우 중요한 역할을 수행하고 있습니다. 이러한 추세는 의약품 개발에 주력하면서 업무 효율화를 도모하는 신흥 바이오의약품 기업에서 특히 두드러집니다.

자주 묻는 질문

생물안전성 시험 서비스 시장 규모는 어떻게 예측되나요?
- 2025년에 42억 달러, 2026년에 47억 달러, 2033년까지 110억 달러로 확대될 것으로 예상되며, 2026-2033년의 CAGR은 12.8%에 이를 것으로 전망됩니다.
생물안전성 시험 서비스 시장에서 북미의 점유율은 어떻게 되나요?
- 2025년에는 북미가 33.3%의 최대 점유율을 기록할 것으로 예상됩니다.
생물안전성 시험 서비스 시장의 성장을 지원하는 요인은 무엇인가요?
- 생물제제 및 바이오시밀러의 채택 확대, 세포·유전자 치료에 대한 관심 증가, 그리고 제품 안전성에 관한 엄격한 규제 요건이 시장 성장을 지원하고 있습니다.
세포·유전자 치료 제품의 파이프라인은 어떻게 변화하고 있나요?
- 현재 약 3,700개의 세포·유전자 치료 제품이 개발 파이프라인에 있으며, 전 세계에서 100개 이상의 치료법이 승인되었습니다.
생물안전성 시험 서비스 수요의 변화는 어떻게 나타나고 있나요?
- 많은 제약사 및 바이오테크 기업이 생물학적 안전성 시험 수요를 전문 서비스 제공업체에 위탁하는 추세가 강화되고 있습니다.
계약연구기관(CRO)과 계약개발·제조기관(CDMO)의 역할은 무엇인가요?
- CRO 및 CDMO는 비용 대비 효과가 높고, 규제를 준수하는 시험 솔루션을 제공하여 의약품 개발에 중요한 역할을 수행하고 있습니다.

The global biological safety testing services market size was valued at USD 4.2 billion in 2025 and is projected to grow from USD 4.7 billion in 2026 to USD 11.0 billion by 2033, at a CAGR of 12.8% from 2026 to 2033. North America dominated the market, accounting for the largest share of 33.3% in 2025. The growth of the biological safety testing services industry is driven by the increasing adoption of biologics and biosimilars, rising focus on cell and gene therapies, and stringent regulatory requirements for product safety.

Moreover, the growing pipeline of biopharmaceutical drugs, coupled with the expansion of contract testing services, has further fueled the market. Technological advancements such as automation, next-generation sequencing (NGS), and polymerase chain reaction (PCR)-based testing are improving efficiency and accuracy, making safety testing more reliable. Furthermore, the biopharmaceutical industry has witnessed significant growth in the past few years. According to the data published by Creative Biogene, approximately 3,700 cell and gene therapy products are in the pipeline currently, with more than 100 approved therapies globally. The growing pipeline of cell and gene therapy products, along with an increasing number of regulatory approvals, is significantly driving the market growth. These advanced therapies require stringent safety assessments to ensure the absence of microbial and viral contaminants. Thus, the growing number of cell and gene therapy product pipelines would boost the demand for these services in the coming year.

In addition, several pharmaceutical and biotechnology companies are increasingly outsourcing their biological safety testing needs to specialized service providers due to the high costs and expertise required for in-house testing. Contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) play a pivotal role in providing cost-effective, regulatory-compliant testing solutions. This trend is particularly strong in emerging biopharmaceutical companies seeking to streamline operations while focusing on drug development.

Global Biological Safety Testing Services Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global biological safety testing services market report based on service, application, end use, and region:

Service Outlook (Revenue, USD Million/Billion, 2021 - 2033)
Bioburden Testing Services
Endotoxin Testing Services
Sterility Testing Services
Viral Clearance and Validation Services
Cell Line Authentication and Characterization Tests
Residual Host Contamination Testing Services
Adventitious Agent Detection Testing Services
Others
Application Outlook (Revenue, USD Million/Billion, 2021 - 2033)
Vaccine & Therapeutics
- Monoclonal Antibodies
- Vaccines
- Recombinant Protein
Cell and Gene Therapy
Blood & Blood Products
Tissue & Tissue-based Products
Others
End Use Outlook (Revenue, USD Million/Billion, 2021 - 2033)
Biopharmaceutical Companies
Pharmaceutical Companies
Academic and Research Institutions
Others
Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Sweden
- Norway
- Denmark
Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Oman
- Qatar

Chapter 1. Research Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Service
- 1.2.2. Application
- 1.2.3. End Use
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.4.3. Secondary Sources
- 1.4.4. Primary Research
1.5. Information Or Data Analysis
- 1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity Flow Analysis
- 1.7.2. Top-Down Analysis
- 1.7.3. Bottom-Up Approach
- 1.7.4. Multivariate Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Biological Safety Testing Services Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Tariff Impact Analysis
3.6. Value Chain Analysis
- 3.6.1. Supply Trends
- 3.6.2. Demand Trends
3.7. Market Analysis Tools
- 3.7.1. Porter's Five Forces Analysis
- 3.7.2. PESTEL by SWOT Analysis

Chapter 4. Biological Safety Testing Services Market: Service Estimates & Trend Analysis

4.1. Service Market Share, 2025 & 2033
4.2. Service Type Segment Dashboard
4.3. Biological Safety Testing Services Market: Service Movement Analysis
4.4. Global Biological Safety Testing Services Market Size & Trend Analysis, by Service, 2021 to 2033 (USD Million/Billion)
4.5. Bioburden Testing Services
- 4.5.1. Bioburden Testing Services Market Estimates & Forecasts, 2021 to 2033 (USD Million/Billion)
4.6. Endotoxin Testing Services
- 4.6.1. Endotoxin Testing Services Market Estimates & Forecasts, 2021 to 2033 (USD Million/Billion)
4.7. Sterility Testing Services
- 4.7.1. Sterility Testing Services Market Estimates & Forecasts, 2021 to 2033 (USD Million/Billion)
4.8. Viral Clearance and Validation Services
- 4.8.1. Viral Clearance and Validation Services Market Estimates & Forecasts, 2021 to 2033 (USD Million/Billion)
4.9. Cell Line Authentication and Characterization Tests
- 4.9.1. Cell Line Authentication and Characterization Tests Market Estimates & Forecasts, 2021 to 2033 (USD Million/Billion)
4.10. Residual Host Contamination Testing Services
- 4.10.1. Residual Host Contamination Testing Services Market Estimates & Forecasts, 2021 to 2033 (USD Million/Billion)
4.11. Adventitious Agent Detection Testing Services
- 4.11.1. Adventitious Agent Detection Testing Services Market Estimates & Forecasts, 2021 to 2033 (USD Million/Billion)
4.12. Others
- 4.12.1. Others Market Estimates & Forecasts, 2021 to 2033 (USD Million/Billion)

Chapter 5. Biological Safety Testing Services Market: Application Estimates & Trend Analysis

5.1. Application Market Share, 2025 & 2033
5.2. Application Segment Dashboard
5.3. Global Biological Safety Testing Services Market: Application Movement Analysis
5.4. Global Biological Safety Testing Services Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million/Billion)
5.5. Vaccine & Therapeutics
- 5.5.1. Vaccine & Therapeutics Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 5.5.2. Monoclonal Antibodies
  - 5.5.2.1. Monoclonal Antibodies Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 5.5.3. Vaccines
  - 5.5.3.1. Vaccines Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 5.5.4. Recombinant Protein
  - 5.5.4.1. Recombinant Protein Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
5.6. Cell and Gene Therapy
- 5.6.1. Cell and Gene Therapy Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
5.7. Blood & Blood Products
- 5.7.1. Blood & Blood Products Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
5.8. Tissue & Tissue-based Products
- 5.8.1. Tissue & Tissue-based Products Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
5.9. Others
- 5.9.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 6. Biological Safety Testing Services Market: End Use Estimates & Trend Analysis

6.1. End Use Market Share, 2025 & 2033
6.2. End Use Segment Dashboard
6.3. Biological Safety Testing Services Market: End Use Movement Analysis
6.4. Global Biological Safety Testing Services Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million/Billion)
6.5. Biopharmaceutical Companies
- 6.5.1. Biopharmaceutical Companies Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
6.6. Pharmaceutical Companies
- 6.6.1. Pharmaceutical Companies Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
6.7. Academic and Research Institutions
- 6.7.1. Academic and Research Institutions Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
6.8. Others
- 6.8.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 7. Biological Safety Testing Services Market: Regional Estimates & Trend Analysis

7.1. Regional Market Dashboard
7.2. Biological Safety Testing Services Market: Regional Movement Analysis
7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
7.4. North America
- 7.4.1. North America Biological Safety Testing Services Market Estimates & Forecasts, By Country, 2021 - 2033 (USD Million/Billion)
- 7.4.2. U.S.
  - 7.4.2.1. Key Country Dynamics
  - 7.4.2.2. Regulatory Framework
  - 7.4.2.3. U.S. Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.4.3. Canada
  - 7.4.3.1. Key Country Dynamics
  - 7.4.3.2. Regulatory Framework
  - 7.4.3.3. Canada Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.4.4. Mexico
  - 7.4.4.1. Key Country Dynamics
  - 7.4.4.2. Regulatory Framework
  - 7.4.4.3. Mexico Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
7.5. Europe
- 7.5.1. Europe Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.5.2. UK
  - 7.5.2.1. Key Country Dynamics
  - 7.5.2.2. Regulatory Framework
  - 7.5.2.3. UK Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.5.3. Germany
  - 7.5.3.1. Key Country Dynamics
  - 7.5.3.2. Regulatory Framework
  - 7.5.3.3. Germany Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.5.4. France
  - 7.5.4.1. Key Country Dynamics
  - 7.5.4.2. Regulatory Framework
  - 7.5.4.3. France Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.5.5. Italy
  - 7.5.5.1. Key Country Dynamics
  - 7.5.5.2. Regulatory Framework
  - 7.5.5.3. Italy Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.5.6. Spain
  - 7.5.6.1. Key Country Dynamics
  - 7.5.6.2. Regulatory Framework
  - 7.5.6.3. Spain Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.5.7. Denmark
  - 7.5.7.1. Key Country Dynamics
  - 7.5.7.2. Regulatory Framework
  - 7.5.7.3. Denmark Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.5.8. Sweden
  - 7.5.8.1. Key Country Dynamics
  - 7.5.8.2. Regulatory Framework
  - 7.5.8.3. Sweden Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.5.9. Norway
  - 7.5.9.1. Key Country Dynamics
  - 7.5.9.2. Regulatory Framework
  - 7.5.9.3. Norway Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
7.6. Asia Pacific
- 7.6.1. Asia Pacific Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.6.2. Japan
  - 7.6.2.1. Key Country Dynamics
  - 7.6.2.2. Regulatory Framework
  - 7.6.2.3. Japan Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.6.3. China
  - 7.6.3.1. Key Country Dynamics
  - 7.6.3.2. Regulatory Framework
  - 7.6.3.3. China Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.6.4. India
  - 7.6.4.1. Key Country Dynamics
  - 7.6.4.2. Regulatory Framework
  - 7.6.4.3. India Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.6.5. Australia
  - 7.6.5.1. Key Country Dynamics
  - 7.6.5.2. Regulatory Framework
  - 7.6.5.3. Australia Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.6.6. South Korea
  - 7.6.6.1. Key Country Dynamics
  - 7.6.6.2. Regulatory Framework
  - 7.6.6.3. South Korea Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.6.7. Thailand
  - 7.6.7.1. Key Country Dynamics
  - 7.6.7.2. Regulatory Framework
  - 7.6.7.3. Thailand Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
7.7. Latin America
- 7.7.1. Latin America Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.7.2. Brazil
  - 7.7.2.1. Key Country Dynamics
  - 7.7.2.2. Regulatory Framework
  - 7.7.2.3. Brazil Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.7.3. Argentina
  - 7.7.3.1. Key Country Dynamics
  - 7.7.3.2. Regulatory Framework
  - 7.7.3.3. Argentina Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
7.8. Middle East and Africa
- 7.8.1. Middle East and Africa Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.8.2. South Africa
  - 7.8.2.1. Key Country Dynamics
  - 7.8.2.2. Regulatory Framework
  - 7.8.2.3. South Africa Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.8.3. Saudi Arabia
  - 7.8.3.1. Key Country Dynamics
  - 7.8.3.2. Regulatory Framework
  - 7.8.3.3. Saudi Arabia Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.8.4. UAE
  - 7.8.4.1. Key Country Dynamics
  - 7.8.4.2. Regulatory Framework
  - 7.8.4.3. UAE Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.8.5. Kuwait
  - 7.8.5.1. Key Country Dynamics
  - 7.8.5.2. Regulatory Framework
  - 7.8.5.3. Kuwait Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.8.6. Oman
  - 7.8.6.1. Key Country Dynamics
  - 7.8.6.2. Regulatory Framework
  - 7.8.6.3. Oman Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)
- 7.8.7. Qatar
  - 7.8.7.1. Key Country Dynamics
  - 7.8.7.2. Regulatory Framework
  - 7.8.7.3. Qatar Biological Safety Testing Services Market Estimates & Forecasts, 2021 - 2033 (USD Million/Billion)

Chapter 8. Competitive Landscape

8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
- 8.5.1. Charles River Laboratories
  - 8.5.1.1. Company overview
  - 8.5.1.2. Financial performance
  - 8.5.1.3. Service benchmarking
  - 8.5.1.4. Strategic initiatives
- 8.5.2. Lonza Group AG
  - 8.5.2.1. Company overview
  - 8.5.2.2. Financial performance
  - 8.5.2.3. Service benchmarking
  - 8.5.2.4. Strategic initiatives
- 8.5.3. Merck KGaA
  - 8.5.3.1. Company overview
  - 8.5.3.2. Financial performance
  - 8.5.3.3. Service benchmarking
  - 8.5.3.4. Strategic initiatives
- 8.5.4. SGS SA
  - 8.5.4.1. Company overview
  - 8.5.4.2. Financial performance
  - 8.5.4.3. Service benchmarking
  - 8.5.4.4. Strategic initiatives
- 8.5.5. Eurofins Scientific
  - 8.5.5.1. Company overview
  - 8.5.5.2. Financial performance
  - 8.5.5.3. Service benchmarking
  - 8.5.5.4. Strategic initiatives
- 8.5.6. WuXi AppTec
  - 8.5.6.1. Company overview
  - 8.5.6.2. Financial performance
  - 8.5.6.3. Service benchmarking
  - 8.5.6.4. Strategic initiatives
- 8.5.7. Thermo Fisher Scientific Inc.
  - 8.5.7.1. Company overview
  - 8.5.7.2. Financial performance
  - 8.5.7.3. Service benchmarking
  - 8.5.7.4. Strategic initiatives
- 8.5.8. Sartorius AG
  - 8.5.8.1. Company overview
  - 8.5.8.2. Financial performance
  - 8.5.8.3. Service benchmarking
  - 8.5.8.4. Strategic initiatives
- 8.5.9. Toxikon Corporation
  - 8.5.9.1. Company overview
  - 8.5.9.2. Financial performance
  - 8.5.9.3. Service benchmarking
  - 8.5.9.4. Strategic initiatives
- 8.5.10. bioMerieux SA
  - 8.5.10.1. Company overview
  - 8.5.10.2. Financial performance
  - 8.5.10.3. Service benchmarking
  - 8.5.10.4. Strategic initiatives

생물 안전 시험 서비스 시장 규모, 점유율 및 동향 분석 보고서 : 서비스별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)